IRIS
Grandi, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.703
EU - Europa 691
AS - Asia 457
SA - Sud America 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 5.864
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.697
CN - Cina 215
IT - Italia 194
SE - Svezia 148
VN - Vietnam 116
FI - Finlandia 109
GB - Regno Unito 83
BG - Bulgaria 57
SG - Singapore 57
TR - Turchia 52
DE - Germania 29
UA - Ucraina 22
FR - Francia 10
NL - Olanda 7
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
BR - Brasile 4
CA - Canada 4
CZ - Repubblica Ceca 4
HK - Hong Kong 4
RO - Romania 4
AU - Australia 3
BE - Belgio 3
IL - Israele 3
CO - Colombia 2
ES - Italia 2
IE - Irlanda 2
IR - Iran 2
MX - Messico 2
PL - Polonia 2
RU - Federazione Russa 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
MU - Mauritius 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 5.864
Salva come PNG Salva come JPEG
Città #
Fairfield 852
Chandler 494
Woodbridge 390
Seattle 368
Ashburn 346
Houston 315
Wilmington 313
Cambridge 309
Ann Arbor 178
Princeton 163
San Mateo 151
Jacksonville 149
Dong Ket 90
Beijing 82
Hangzhou 69
Sofia 57
San Diego 55
Dearborn 53
Izmir 51
Helsinki 49
Trento 35
San Paolo di Civitate 33
New York 31
Phoenix 26
Como 24
London 19
Boardman 16
Norwalk 16
Altamura 15
Singapore 13
Des Moines 8
Fremont 8
Nanjing 8
Schio 8
Tavagnacco 8
Düsseldorf 7
Naples 7
Dallas 6
Guangzhou 6
Hefei 6
Los Angeles 6
Riva Del Garda 6
Shanghai 6
Andover 5
Bratislava 5
Kilburn 5
Parma 5
Augusta 4
Brno 4
Falls Church 4
Fuzhou 4
Hong Kong 4
Hounslow 4
Kunming 4
Nanchang 4
Rome 4
São Paulo 4
Toronto 4
Verona 4
Amsterdam 3
Bolzano 3
Bremen 3
Jinan 3
Padova 3
Paris 3
Pontassieve 3
Washington 3
Acton 2
Annapolis Junction 2
Ansbach 2
Brooklyn 2
Cascais 2
Centro 2
Comabbio 2
Easton 2
Florence 2
Islington 2
Lagundo 2
Lamezia Terme 2
Modena 2
Napoli 2
Pergine Valsugana 2
Prescot 2
Qiryat Ata 2
Quzhou 2
San Francisco 2
Santiago de Cali 2
Southwark 2
Taipei 2
Wandsworth 2
Wuhan 2
Xian 2
Arzano 1
Banham 1
Basra 1
Bassano del Grappa 1
Bonndorf 1
Brentford 1
Bristol 1
Brussels 1
Totale 5.002
Salva come PNG Salva come JPEG
Nome #
Protectome analysis: A new selective bioinformatics tool for bacterial vaccine candidate discovery 197
Structure of the type IX Group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII 185
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models 137
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus 134
Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital 132
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting 128
The human pathogen Streptococcus pyogenes releases lipoproteins as lipoprotein-rich membrane vesicles 127
One dose of staphylococcus aureus 4C-staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T Cells, and IL-17A 122
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface 118
Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD 116
New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly. 116
Understanding the Molecular Determinants Driving the Immunological Specificity of the Protective Pilus 2a Backbone Protein of Group B Streptococcus 115
Targeted amino acid substitutions impair streptolysin O toxicity and group a Streptococcus virulence 113
Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models 110
FAT1: A potential target for monoclonal antibody therapy in colon cancer 109
Analysis of two-component systems in group B streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness 106
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine 105
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population 102
Approach to discover T and B cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. 99
A structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. 97
Vaccinology: The art of putting together the right ingredients 97
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer 95
MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers 94
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles 94
Auto-assembling detoxified staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin 93
SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion 92
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes 87
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro 86
The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera 85
Structural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and Specificity 84
CD81 extracellular domain 3D structure: Insight into the tetraspanin superfamily structural motifs 82
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli 80
Four-component Staphylococcus aureus vaccine 4C-staph enhances fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice 79
Sortase A substrate specificity in GBS pilus 2a cell wall anchoring. 78
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women. 78
Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection 78
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins. 77
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 77
Cloning and nucleotide sequence of the isoamylase gene from a strain of Pseudomonas sp 76
Streptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch model 74
Antibacterial vaccine design using genomics and proteomics 73
Structural vaccinology starts to deliver 72
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer 69
Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. 68
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis 63
Prochymosin expression in Bacillus subtilis 63
Engineering outer membrane vesicles 62
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. 62
Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings 59
Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case. 59
Multiple Stepwise Gene Knockout Using CRISPR/Cas9 in Escherichia coli 59
Structural vaccinology starts to deliver 58
Antibody-mediated immunity induced by engineered Escherichia coli Outer Membrane Vesicles (OMVs) carrying heterologous antigens in their lumen 58
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform 58
The impact of genomics in vaccine discovery: achievements and lessons 56
Recombinant and truncated tetanus neurotoxin light chain: Cloning, expression, purification, and proteolytic activity 56
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen. 55
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 50
A rapid and versatile site-directed method of mutagenesis for double-stranded plasmid DNA 50
TCTN2: A novel tumor marker with oncogenic properties 50
The complete genome sequence of the gram-positive bacterium Bacillus subtilis 49
Rational antibacterial vaccine design through genomic technologies 49
Surface Interactome in Streptococcus pyogenes. 47
Immobilized metal-ion affinity chromatography of human growth hormone 47
Identification of vaccine candidates against serogroup B meningococcus genome sequencing. 41
Cumulative stabilizing effects of hydrophobic interactions on the surface of the neutral protease from Bacillus subtilis 39
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2 39
A Bacillus subtilis large ORF coding for a polypeptide highly similar to polyketide synthases. 37
R-factor mediated suppression of the galacto-sensitive phenotype of E.coli K12 galE mutants. 34
Model building of a thermolysin-like protease by mutagenesis. 33
Characterization of the locus encoding the [Ni-Fe] sulfhydrogenase from the archaeon Pyrococcus furiosus: evidence for a relationship to bacterial sulfite reductases. 32
tructure analysis and site-directed mutagenesis of defined key residues and motives for pilus-related sortase C1 in group B Streptococcus. 31
Efficient conversion of 5-substituted hydantoins to D-amino acids using recombinant E. coli strains 28
Purification of recombinant human growth hormone by isoelectric focusing in a multicompartment electrolyzer with Immobiline membranes. 28
Mining the bacterial unknown proteome: Identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus 28
Identification of novel iron-activated and -repressed fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B 28
Crystal structures of the components of the Staphylococcus aureus leukotoxin ED 24
Grafting of a calcium binding loop of thermolysin to B. subtilis neutral protease. 23
Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes 23
Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus 21
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 20
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines 20
Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development 20
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 19
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 14
Totale 6.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019283 0 0 0 0 0 0 0 0 0 0 177 106
2019/20201.481 54 44 72 145 142 135 207 166 257 131 57 71
2020/20211.432 53 83 54 216 146 152 157 109 57 112 97 196
2021/20221.081 57 149 18 99 28 42 34 219 59 96 118 162
2022/20231.018 150 154 23 134 89 156 10 80 108 8 57 49
2023/2024280 24 34 21 16 30 46 46 14 4 16 29 0
Totale 6.128